Xueliang Wang

Dr. Xueliang Wang


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2023 in Cancer Medicine
Verified
Journal Article
Open access
RZRan Zhao
Ran Zhao
DXDongge Xia
Dongge Xia
YCYingwei Chen
Yingwei Chen
ZKZhentian Kai
Zhentian Kai
FRFangying Ruan
Fangying Ruan
XWXueliang Wang
Xueliang Wang
Background: Conventional blood and stool tests are normally used for early screening of colorectal cancer (CRC) but the accuracy and efficiency remain to be improved. Recent findings suggest Fusobacterium nucleatum to be a biomarker for CRC. This study evaluated the role of F. nucleatum and developed CRC diagnostic models by combining F. nucleatum with fecal occult blood (FOB), transferrin (TRF), carcinoembryonic antigen (CEA), carbohydrate antigen 19‐9 (CA19‐9), gender, and age.Materials and Methods: Candidates including 71 healthy individuals and 59 CRC patients were recruited. Abundance of F. nucleatum in stool or tissue samples was measured by quantitative real‐time PCR. CEA, CA19‐9, TRF, and FOB were measured in parallel. These biomarkers together with genders and ages were the seven parameters used to develop CRC diagnostic models. Ten different machine learning algorithms were tested to achieve the best performance.Results: Fecal F. nucleatum abundance was found significantly higher in CRC group compared to healthy group (p = 0.0005). Among the CRC patients, F. nucleatum abundance in tumor tissue was significantly higher than that in paracancerous tissue (p = 0.0087). CRC diagnostic models using different parameters were generated based on Logistic Regression algorithm, which showed good performance. The area under the curve (AUC) score of fecal F. nucleatum as the single diagnostic biomarker was 0.68 while the accuracy was 0.56. The diagnostic performance was obviously improved with the highest AUC (0.93) and accuracy (0.87) achieved when using all the 7 clinical parameters. The combination F. nucleatum + FOB + gender + age had the second highest AUC (0.92) and accuracy (0.85). A more utilitarian model using F. nucleatum + FOB showed relatively high AUC at 0.86 and accuracy at 0.81.Conclusions: F. nucleatum is valuable for CRC diagnosis. Combination of different clinical parameters could significantly improve CRC diagnostic performance. The combination F. nucleatum + FOB + gender + age may be an effective and noninvasive method for clinical application.

1 October 2024 in Analytica Chimica Acta
Verified
Journal Article
Closed access
YCYingwei Chen
Yingwei Chen
RZRan Zhao
Ran Zhao
XHXiaobo Hu
Xiaobo Hu
XWXueliang Wang
Xueliang Wang

20 July 2022 in Clinical Chemistry and Laboratory Medicine (CCLM)
Verified
Journal Article
Closed access
XFXiaoyu Fan
Xiaoyu Fan
CSChunli Shi
Chunli Shi
MWMeng Wei
Meng Wei
YXYanqun Xiao
Yanqun Xiao
XWXueliang Wang
Xueliang Wang
Objectives: Detection of Syndecan 2 (SDC2) methylation in stool DNA is a novel method for the auxiliary diagnosis of early colorectal cancer (CRC). Currently, this method has been widely applied; however, its accuracy and reliability have not been determined. The objective of this pioneering study was to evaluate the performance of clinical laboratories in China for their ability to detect SDC2 methylation from stool DNA. Methods: We generated a sample panel consisting of clinical and cell samples. The clinical samples were stool specimens from patients with or without CRC, including four positives (prepared by serial dilution from one stool specimen), one negative and one interferential sample. Two cell samples, with positive or negative methylated SDC2, were used as controls. The panel was distributed to 32 clinical laboratories for analysis of SDC2 methylation, and the results were compared and scored. Results: The sample panel was compatible with commercially available assays and it showed appropriate stability to be an external quality assessment material. There were four false results; one hospital laboratory and one commercial diagnostic laboratory had a false-positive and a false-negative result, respectively, and one commercial diagnostic laboratory had both a false-positive and false-negative result. Among the 32 participating laboratories, 29 (90.62%) obtained an acceptable or better performance score, while 3 (9.38%) laboratories required improvement. Conclusions: Our results demonstrate that the detection of SDC2 methylation from stool DNA was satisfactory in China. Additionally, the importance of external quality assessment was highlighted for monitoring the performance of clinical laboratories.

28 March 2025 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
PDF file
ZHZhongqiang Huang
Zhongqiang Huang
JSJian Song
Jian Song
CSChunli Shi
Chunli Shi
XFXiaoyu Fan
Xiaoyu Fan
YXYanqun Xiao
Yanqun Xiao
XWXueliang Wang
Xueliang Wang
The main detection method for viral respiratory infections is reverse transcription polymerase chain reaction (RT–PCR), but it is susceptible to sample inhibitors and relies on a standard curve and subjective thresholds to quantify nucleic acid targets. However, droplet digital PCR (ddPCR), the third generation of PCR with higher sensitivity and accuracy, is an effective tool for the detection and absolute quantification of respiratory viruses. In this study, we introduced AHQR–ddPCR, which is an automated and high-throughput quadruplex reverse transcription ddPCR assay based on the QX ONE platform for the detection of influenza A, influenza B, respiratory syncytial virus, and SARS-CoV-2 in a single reaction. The AHQR–ddPCR assay had analytical sensitivity as low as 0.65–0.78 copies/μL for four respiratory viruses, and exhibited excellent analytical specificity, intraassay and interassay precision, and a wide linear range for each viral target. The results in clinical samples showed that the assay had good concordance and better diagnostic sensitivity compared to RT-PCR. In short, the highly sensitive and absolutely quantitative AHQR–ddPCR assay has excellent analytical and clinical performance, and the advantage of detecting weakly positive samples, which can effectively reduce false-negative results and is a powerful complement to RT–PCR. In addition, it has great value for virology research and the development of automated molecular assays.

1 July 2021 in Journal of Virological Methods
Verified
Journal Article
Closed access
XWXueliang Wang
Xueliang Wang
ZHZhongqiang Huang
Zhongqiang Huang
JSJian Song
Jian Song
YXYanqun Xiao
Yanqun Xiao
HWHualiang Wang
Hualiang Wang

13 September 2025 in Bioelectrochemistry
Verified
Journal Article
Closed access
ZWZhangmin Wang
Zhangmin Wang
XFXiaoyu Fan
Xiaoyu Fan
XHXiaobo Hu
Xiaobo Hu
XWXueliang Wang
Xueliang Wang